News About: Pharm. Industry
Maxmarvil awarded as the 100 outstanding patented products.Maxmarvil, a combined anti-osteoporosis drug developed by Yuyu, was awarded by the Patent Office for an outstanding patented product in the 4th top 100 outstanding patented prod...
|
2 additional cancer centers to establish in 2006.
The MOHW announced on Jan. 11 that two regional cancer centers would be newly established in 2006 for the purpose of minimizing any social costs caused by fatal diseases with an early diagnosis and treatment.
2 can...
Drug industry to put aggressive internet marketing.
Advertising cost saving and more efficient channels for product informations directly to consumers have attracted the drug company to put aggressive marketing activities through the portal sites.
Kwangdong, Boryung...
Abbott to launch RS Virus antibody.Abbott Korea announced to launch Synagis (palivizumab), a monoclonal antibody for the prevention of serious respiratory infection due to respiratory syncytial virus (RSV) infect...
|
Eloxatin liquid form to launch in April.A new liquid injectable form of Eloxatin, which was supplied in a freeze dried powder form of anti colon cancer drug, seems to be launched soon to make ready to administer at ho...
|
Handok to forecast 250 BW of sales in 2006.
Handok announced the 2006 sales forecast at 250 billion won, about 7% up from 2005.
Handok made the total 6.4 billion won of investment for the manufacturing facilities, about 77% more than 2005, and planned to lau...
Kwangdong/Finechem trying a joint R&D for new bulk drugs.
Kwangdong agreed with Finechem, a bio venture company of Korea, on Jan. 10 for the local production of new bulk drugs.
Under the agreement, Kwangdong takes responsibilities for the dosage studies, stability tests, ...
Daejeon regional KFDA to punish 43 drug companies.
Daejeon regional KFDA inspected drug companies during the 4th quarter last year and charged 43 companies including Dong-A and LG Life Science to suspend production or cancel the product registration on charge of poor ...
Nexgen to join WHO's R&D project for rabies antibody
Nexgen, a plant genetic engineering venture company, announced on Jan. 10 about their participation in the WHO's project for the rabies antibody development by the use of plant as a part of "Pharma-Planta consortium" ...
Pfizer Korea to launch Rogaine for anti-alopecia.Rogaine, a world reputed brand drug for a hair loss, will be soon introduced to Korea.
Pfizer Korea has gained a good popularity in the OTC drug markets with no-smoking and a...
|
